Are you or your loved ones suffering from glioma and glioblastoma?

You may be eligible to participate in a glioma and glioblastoma clinical trial.

Are you or your loved ones suffering from glioma and glioblastoma? You may be eligible to participate in a glioma and glioblastoma clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Glioblastoma (GBM) and H3 K27M-mutant Glioma in Boston MA
NCT02525692 | Phase 2 | Interventional
Oncoceutics Inc
Sponsored by
Oncoceutics Inc

Are you or your loved ones suffering from glioma and glioblastoma?

You may be eligible to participate in a glioma and glioblastoma clinical trial.

Are you or your loved ones suffering from glioma and glioblastoma? You may be eligible to participate in a glioma and glioblastoma clinical trial.

Recruiting

Male & Female

16 +

years old

This study is looking to recruit 76 Participants

ONC201 is a new drug candidate that kills cancer cells but not normal cells in laboratory studies and has been previously evaluated in a phase I clinical trial in advanced cancer patients. This clinical trial will enroll patients with recurrent glioblastoma or recurrent WHO Grade IV gliomas with the H3 K27M mutation.

Where you'll go

Selected location

Dana Farber Cancer Institute

Dana Farber Cancer Institute Change

450 Brookline Avenue, Boston, MA, USA 02115 Map | Learn more
Available locations
Massachusetts General Hospital

Massachusetts General Hospital

Recruiting 15 Parkman Street, Boston, MA, USA 02114

Miami Cancer Institute

Miami Cancer Institute

Recruiting 8900 North Kendall Drive, Miami, FL, USA 33176

Interested in participating?
Selected location

Dana Farber Cancer Institute

450 Brookline Avenue, Boston, MA, USA 02115

Patrick Wen, MD 617-632-2166
Dana-FarberContactUs@dfci.harvard.edu


The information you provide is confidential and is never sold or shared with outside vendors. By clicking the button, you agree to the PatientWing's Terms and Privacy Policy.